Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

IKK/NF-κB signaling: balancing life and death – a new approach to cancer therapy
Jun-Li Luo, … , Hideaki Kamata, Michael Karin
Jun-Li Luo, … , Hideaki Kamata, Michael Karin
Published October 3, 2005
Citation Information: J Clin Invest. 2005;115(10):2625-2632. https://doi.org/10.1172/JCI26322.
View: Text | PDF
Review Series Article has an altmetric score of 7

IKK/NF-κB signaling: balancing life and death – a new approach to cancer therapy

  • Text
  • PDF
Abstract

IκB kinase/NF-κB (IKK/NF-κB) signaling pathways play critical roles in a variety of physiological and pathological processes. One function of NF-κB is promotion of cell survival through induction of target genes, whose products inhibit components of the apoptotic machinery in normal and cancerous cells. NF-κB can also prevent programmed necrosis by inducing genes encoding antioxidant proteins. Regardless of mechanism, many cancer cells, of either epithelial or hematopoietic origin, use NF-κB to achieve resistance to anticancer drugs, radiation, and death cytokines. Hence, inhibition of IKK-driven NF-κB activation offers a strategy for treatment of different malignancies and can convert inflammation-induced tumor growth to inflammation-induced tumor regression.

Authors

Jun-Li Luo, Hideaki Kamata, Michael Karin

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 Total
Citations: 4 18 21 25 25 18 25 9 20 13 20 19 18 10 13 21 30 23 15 9 1 357
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2013 (18)

Title and authors Publication Year
Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia
A Katsha, M Soutto, V Sehdev, D Peng, MK Washington, MB Piazuelo, MN Tantawy, HC Manning, P Lu, Y Shyr, J Ecsedy, A Belkhiri, W El-Rifai
Gastroenterology 2013
Antioxidant Function of Isoflavone and 3,3′-Diindolylmethane: Are They Important for Cancer Prevention and Therapy?
Y Li, D Kong, A Ahmad, B Bao, FH Sarkar
Antioxidants & Redox Signaling 2013
Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society
N Duru, D Candas, G Jiang, JJ Li
Journal of Cancer Research and Clinical Oncology 2013
The Inflammatory Tissue Microenvironment in IBD:
SP Colgan, VF Curtis, EL Campbell
Inflammatory Bowel Diseases 2013
Genes Related to Suppression of Malignant Phenotype Induced by Maitake D-Fraction in Breast Cancer Cells
EN Alonso, M Orozco, AE Nieto, GA Balogh
Journal of Medicinal Food 2013
NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
Y Fan, R Mao, J Yang
Protein & Cell 2013
Targeting apoptosis pathways in cancer with alantolactone and isoalantolactone
A Rasul, M Khan, M Ali, J Li, X Li
The Scientific World JOURNAL 2013
Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes
DA Flusberg, J Roux, SL Spencer, PK Sorger, DD Newmeyer
Molecular biology of the cell 2013
Molecular mechanisms of luteolin-7-O-glucoside-induced growth inhibition on human liver cancer cells: G2/M cell cycle arrest and caspase-independent apoptotic signaling pathways
Hwang YJ, Lee EJ, Kim HR, Hwang KA
BMB Reports 2013
Chemoprevention of Head and Neck Squamous Cell Carcinoma through Inhibition of NF-κB Signaling
Vander Broek R, Snow GE, Chen Z, Van Waes C
Oral Oncology 2013
Inhibitor κB Kinase 2 is a Myosin Light Chain Kinase in Vascular Smooth Muscle
Ying Z, do Carmo JM, Xiang L, da Silva AA, Chen M, Ryan MJ, Ostrowski M, Rajagopalan S, Hall JE
Circulation research 2013
Selective TBK1/IKKi dual inhibitors with anti-cancer potency
Li J, Huang J, Jeong JH, Park SJ, Wei R, Peng J, Luo Z, Chen YT, Feng Y, Luo JL
International Journal of Cancer 2013
Therapeutic potential of curcumin in digestive diseases
Dulbecco P, Savarino V
World journal of gastroenterology : WJG 2013
TNFR1 Signaling Kinetics: Spatiotemporal Control of Three Phases of IKK activation by Posttranslational Modification
Workman LM, Habelhah H
Cellular Signalling 2013
Abrogated Thioredoxin System Causes Increased Sensitivity to TNF-α-Induced Apoptosis via Enrichment of p-ERK 1/2 in the Nucleus
Yoo MH, Carlson BA, Gladyshev VN, Hatfield DL
PloS one 2013
Oncosuppressive Suicide Gene Virotherapy “PVH1-yCD/5-FC” for Pancreatic Peritoneal Carcinomatosis Treatment: NFκB and Akt/PI3K Involvement
Réjiba S, Bigand C, Parmentier C, Masmoudi A, Hajri A
PloS one 2013
TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence
Chefetz I, Alvero AB, Holmberg JC, Lebowitz N, Craveiro V, Yang-Hartwich Y, Yin G, Squillace L, Soteras MG, Aldo P, Mor G
Cell cycle (Georgetown, Tex.) 2013
The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).
Morris G, Berk M, Galecki P, Maes M
Molecular Neurobiology 2013

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Referenced in 47 patents
484 readers on Mendeley
3 readers on CiteULike
See more details